Seres Therapeutics, Inc. (MCRB) — SC 13G/A Filings
All SC 13G/A filings from Seres Therapeutics, Inc.. Browse 3 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (3)
- SC 13G/A Filing — Apr 5, 2024
-
Janus Henderson Amends Seres Therapeutics Stake
— Feb 12, 2024 Risk: low
Janus Henderson Group plc, an investment management firm, filed an amended SC 13G/A on February 12, 2024, disclosing its beneficial ownership of Seres Therapeut -
FMR LLC & Abigail Johnson Trim Seres Therapeutics Stake to 14.999%
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its Chair and CEO, Abigail P. Johnson, have updated their ownership stake in Seres Therapeutics, Inc. (NASDAQ: MCRB) to 14
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX